The pharmaceutical industry has long been coping with the issue of counterfeit or spurious drugs, and the challenges have only been exacerbated by the disruptions caused by the Covid-19 pandemic. According to a recent report published by CRISIL-ASPA on the State of Counterfeiting in India 2022, industry insiders estimate that 0.1-3% of medicines manufactured and sold in India are counterfeit, while distributors and authentication solution providers believe the number could be as high as 10-20% of the overall pharmaceutical market. TRACESCI, a participant in the upcoming PharmaTech exhibition in Chandigarh from April 11-13, 2023, aims to create awareness in the market that intervention is necessary. The circulation of counterfeit drugs is detrimental to the growth of the pharma industry, and adopting anti-counterfeiting measures at the manufacturing location is crucial.
TRACESCI advocates for the adoption of blockchain-based track and trace solutions that can provide manufacturers with 360-degree visibility and control over their supply chains.
“With TRACESCI, a brand can obtain an effective product authentication solution that includes tracking legitimate products throughout the supply chain, a consumer engagement app, and an efficient reporting system, all under one unique SAAS-based track and trace platform,” said Priyanka Rathi, DGM Marketing& Communication at JETSCI® Global& TRACESCI Global.
Kunal Kothari, Product Manager at TRACESCI Global, added, “As a global specialist in product authentication and traceability, we are successfully fortifying governments and brands alike through our intuitive, innovative blockchain-based supply chain manufacturer interface. With TRACESCI, traceability is just a tap away.”
To learn more and participate in free demo sessions, visit the TRACESCI Global booth at PharmaTech& LabTech Expo in Chandigarh from April 11-13, 2023, booth number B-39, Hall no. 2.